Products for Research Use Only

Doxepin

CAT: 0804-HY-B0725ASize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-B0725ASize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant. Doxepin has therapeutic effects in atopic dermatitis, chronic urticarial, can improve cognitive processes, protect central nervous system. Doxepin has also been proposed as a protective factor against oxidative stress[1][2][3].
CAS Number
1668-19-5
UNSPSC
12352005
Target
Akt; mTOR; PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/doxepin.html
Solubility
10 mM in DMSO
Smiles
CN(C)CC/C=C1C2=CC=CC=C2OCC3=CC=CC=C/13
Molecular Formula
C19H21NO
Molecular Weight
279.38
References & Citations
[1]AnnemiekVermeeren, et al. Effects of the use of hypnotics on cognition. Progress in brain research vol. 190 (2011) : 89-103.|[2]G Hajak, et al. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. The Journal of clinical psychiatry vol. 62,6 (2001) : 453-63.|[3]Mahsa Gharzi, et al. Effects of different doses of doxepin on passive avoidance learning in rats. Advanced biomedical research vol. 2 66. 30 Jul. 2013. |[4]Jimei Bu, et al. Mechanism underlying the effects of doxepin on β-amyloid -induced memory impairment in rats. Iran J Basic Med Sci. 2017 Sep;20 (9) :1044-1049.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Launched
Citation 01
J Appl Toxicol. 2023 Oct;43 (10) :1421-1435.|Nat Commun. 2022 Nov 10;13 (1) :6796.|Antiviral Res. 2025 Dec:244:106307.|Cell Commun Signal. 2023 May 25;21 (1) :123.|Pharm Res. 2025 Aug;42 (8) :1315-1329.|Virus Res. 2022 Aug:317:198816.